$ROIV
Roivant Sciences Ltd.

2024 Q4 Form 10-Q Financial Statement

#000114036124046019 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $4.475M $37.10M
YoY Change -87.94% 196.03%
Cost Of Revenue $234.0K $3.270M
YoY Change -92.84% -10.19%
Gross Profit $4.241M $33.84M
YoY Change -87.47% 280.57%
Gross Profit Margin 94.77% 91.21%
Selling, General & Admin $236.5M $164.4M
YoY Change 43.87% 4.24%
% of Gross Profit 5575.52% 485.68%
Research & Development $143.1M $132.0M
YoY Change 8.4% -0.01%
% of Gross Profit 3373.57% 390.02%
Depreciation & Amortization $4.842M $5.600M
YoY Change -13.54% -27.77%
% of Gross Profit 114.17% 16.55%
Operating Expenses $346.2M $313.6M
YoY Change 10.41% 6.91%
Operating Profit -$341.7M -$276.5M
YoY Change 23.61% -1.54%
Interest Expense $118.1M $9.247M
YoY Change 1177.69% -116.13%
% of Operating Profit
Other Income/Expense, Net -$1.453M -$5.931M
YoY Change -75.5% -31.15%
Pretax Income -$224.4M -$327.4M
YoY Change -31.46% 4.34%
Income Tax $12.46M $3.757M
% Of Pretax Income
Net Earnings -$230.2M -$304.3M
YoY Change -24.36% 4.37%
Net Earnings / Revenue -5143.78% -820.27%
Basic Earnings Per Share -$0.31 -$0.40
Diluted Earnings Per Share -$0.31 -$0.40
COMMON SHARES
Basic Shares Outstanding 727.9M 739.5M 771.7M
Diluted Shares Outstanding 735.5M 770.2M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.387B $1.408B
YoY Change 282.52% -11.93%
Cash & Equivalents $1.959B $1.408B
Short-Term Investments $3.428B
Other Short-Term Assets $94.23M $143.4M
YoY Change -34.29% 28.21%
Inventory $4.905M
Prepaid Expenses $54.84M $60.72M
Receivables $1.916M $52.10M
Other Receivables $20.77M $2.500M
Total Short-Term Assets $5.801B $1.552B
YoY Change 273.87% -9.52%
LONG-TERM ASSETS
Property, Plant & Equipment $13.67M $24.48M
YoY Change -44.14% -37.51%
Goodwill
YoY Change
Intangibles $140.6M
YoY Change 0.23%
Long-Term Investments $311.4M $250.4M
YoY Change 24.34% 1.54%
Other Assets $36.90M $49.80M
YoY Change -25.89% 319.37%
Total Long-Term Assets $404.9M $513.9M
YoY Change -21.21% 2.65%
TOTAL ASSETS
Total Short-Term Assets $5.801B $1.552B
Total Long-Term Assets $404.9M $513.9M
Total Assets $6.206B $2.066B
YoY Change 200.46% -6.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.13M $44.12M
YoY Change -43.05% 6.69%
Accrued Expenses $111.5M $152.9M
YoY Change -27.11% 18.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $49.00M
YoY Change 37.04%
Total Short-Term Liabilities $556.2M $265.5M
YoY Change 109.47% 15.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $389.4M
YoY Change -100.0% 3.55%
Other Long-Term Liabilities $295.0K $5.175M
YoY Change -94.3% -43.16%
Total Long-Term Liabilities $295.0K $5.175M
YoY Change -94.3% -43.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $556.2M $265.5M
Total Long-Term Liabilities $295.0K $5.175M
Total Liabilities $626.0M $739.9M
YoY Change -15.4% 5.49%
SHAREHOLDERS EQUITY
Retained Earnings $395.6M -$4.400B
YoY Change -108.99% 29.9%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.153B $948.5M
YoY Change
Total Liabilities & Shareholders Equity $6.206B $2.066B
YoY Change 200.46% -6.77%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$230.2M -$304.3M
YoY Change -24.36% 4.37%
Depreciation, Depletion And Amortization $4.842M $5.600M
YoY Change -13.54% -27.77%
Cash From Operating Activities -$266.8M -$196.5M
YoY Change 35.78% 3.62%
INVESTING ACTIVITIES
Capital Expenditures $996.0K $300.0K
YoY Change 232.0% -109.67%
Acquisitions
YoY Change
Other Investing Activities -$3.293B -$36.20M
YoY Change 8995.57% -74.82%
Cash From Investing Activities -$3.294B -$36.40M
YoY Change 8948.34% -75.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -109.1M 207.8M
YoY Change -152.49% -2930.68%
NET CHANGE
Cash From Operating Activities -266.8M -196.5M
Cash From Investing Activities -3.294B -36.40M
Cash From Financing Activities -109.1M 207.8M
Net Change In Cash -3.669B -25.10M
YoY Change 14519.42% -92.7%
FREE CASH FLOW
Cash From Operating Activities -$266.8M -$196.5M
Capital Expenditures $996.0K $300.0K
Free Cash Flow -$267.8M -$196.8M
YoY Change 36.08% 5.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">(B) Use of Estimates</div> <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to assets, liabilities, costs, expenses, contingent liabilities, share-based compensation and research and development costs. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</div>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1958633000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
94226000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
80605000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5801119000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42977000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44002000
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
311354000
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
247753000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36904000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37701000
CY2024Q3 us-gaap Assets
Assets
6206028000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
25127000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
14029000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
111469000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119417000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9519000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8966000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8921000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13941000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
556249000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
266758000
CY2024Q3 roiv Liability Instruments Measured At Fair Value
LiabilityInstrumentsMeasuredAtFairValue
26252000
CY2024Q1 roiv Liability Instruments Measured At Fair Value
LiabilityInstrumentsMeasuredAtFairValue
25737000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45020000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
295000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2493000
CY2024Q3 us-gaap Liabilities
Liabilities
625986000
CY2024Q1 us-gaap Liabilities
Liabilities
773953000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000000341740141
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000000341740141
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4775411000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
395580000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
576172000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18036000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4083000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5152955000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5968581000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
427087000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
479948000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5580042000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6448529000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6206028000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7222482000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Registrant Name
EntityRegistrantName
ROIVANT SCIENCES LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D0
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1173944
dei Entity Address Address Line1
EntityAddressAddressLine1
7th Floor
dei Entity Address Address Line2
EntityAddressAddressLine2
50 Broadway
dei Entity Address City Or Town
EntityAddressCityOrTown
London
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
SW1H 0DB
dei Entity Address Country
EntityAddressCountry
GB
dei Country Region
CountryRegion
44
dei City Area Code
CityAreaCode
207
dei Local Phone Number
LocalPhoneNumber
400 3347
dei Security12b Title
Security12bTitle
Common Shares, $0.0000000341740141 per share
dei Trading Symbol
TradingSymbol
ROIV
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
727949744
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6494953000
CY2024Q1 us-gaap Assets
Assets
7222482000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5396492000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001635088
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40782
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3428021000
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
320239000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
156270000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
6731828000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13674000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15322000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
145876000
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
401213000
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
110405000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43190000
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
433945000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
733328375
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
733328375
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
806677954
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
806677954
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4475000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3648000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12465000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8131000
CY2024Q3 roiv Operating Costs
OperatingCosts
234000
CY2023Q3 roiv Operating Costs
OperatingCosts
223000
roiv Operating Costs
OperatingCosts
447000
roiv Operating Costs
OperatingCosts
1206000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143073000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114790000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
263580000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
224206000
CY2024Q3 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
0
CY2023Q3 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
13950000
roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
0
roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
26450000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
202881000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88576000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
302773000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
179858000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
346188000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
217539000
us-gaap Operating Expenses
OperatingExpenses
566800000
us-gaap Operating Expenses
OperatingExpenses
431720000
CY2024Q3 roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
0
CY2023Q3 roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
0
roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
110387000
roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
0
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-341713000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-213891000
us-gaap Operating Income Loss
OperatingIncomeLoss
-443948000
us-gaap Operating Income Loss
OperatingIncomeLoss
-423589000
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
48375000
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-45849000
us-gaap Gain Loss On Investments
GainLossOnInvestments
63601000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-53413000
CY2024Q3 roiv Gain Loss On Fair Value Of Liability Instruments
GainLossOnFairValueOfLiabilityInstruments
635000
CY2023Q3 roiv Gain Loss On Fair Value Of Liability Instruments
GainLossOnFairValueOfLiabilityInstruments
-11789000
roiv Gain Loss On Fair Value Of Liability Instruments
GainLossOnFairValueOfLiabilityInstruments
-515000
roiv Gain Loss On Fair Value Of Liability Instruments
GainLossOnFairValueOfLiabilityInstruments
-51967000
CY2024Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0
CY2023Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
CY2024Q3 roiv Interest Income
InterestIncome
69773000
CY2023Q3 roiv Interest Income
InterestIncome
14299000
roiv Interest Income
InterestIncome
141900000
roiv Interest Income
InterestIncome
31014000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1453000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1530000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5061000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4357000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-224383000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-241406000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-244023000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-484958000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12458000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3236000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24421000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4911000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-236841000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-244642000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-268444000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-489869000
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-43083000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-86476000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
46010000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-169094000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-279924000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
us-gaap Profit Loss
ProfitLoss
-222434000
us-gaap Profit Loss
ProfitLoss
-658963000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-49740000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-26791000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-87547000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-62820000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-230184000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-304327000
us-gaap Net Income Loss
NetIncomeLoss
-134887000
us-gaap Net Income Loss
NetIncomeLoss
-596143000
CY2024Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-187101000
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-218226000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-181052000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-427784000
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-43083000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-86101000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
46165000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-168359000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-230184000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-304327000
us-gaap Net Income Loss
NetIncomeLoss
-134887000
us-gaap Net Income Loss
NetIncomeLoss
-596143000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.25
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.25
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.28
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.28
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.25
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.25
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.56
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.56
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.06
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.11
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.11
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.06
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.06
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.22
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.22
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
735470796
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
770227849
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
735642721
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
764780630
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
735470796
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
770227849
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
735642721
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
764780630
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-279924000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
us-gaap Profit Loss
ProfitLoss
-222434000
us-gaap Profit Loss
ProfitLoss
-658963000
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
7100000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
-3500000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
0
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6894000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3602000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-10126000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-546000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
206000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3602000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13626000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-546000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-279718000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-327516000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-236060000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-659509000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-49446000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-26727000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-87220000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-62911000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-230272000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-300789000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-148840000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-596598000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6448529000
CY2024Q2 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
11147000
CY2024Q2 roiv Net Issuance Of Subsidiary Common Shares Value
NetIssuanceOfSubsidiaryCommonSharesValue
11647000
CY2024Q2 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
745000
CY2024Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
648385000
CY2024Q2 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
50239000
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
-10600000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3232000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
57490000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5895286000
CY2024Q3 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
2597000
CY2024Q3 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
762000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
648000
CY2024Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
106054000
CY2024Q3 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
71715000
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
7100000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6894000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-279924000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5580042000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1607587000
CY2023Q2 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
-14395000
CY2023Q2 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
890000
CY2023Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2023Q2 roiv Dividend Declared By Subsidiary
DividendDeclaredBySubsidiary
6000000
CY2023Q2 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
49260000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4148000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-327845000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1334139000
CY2023Q3 roiv Stock Issued During Period Value Net Issuance Costs
StockIssuedDuringPeriodValueNetIssuanceCosts
199822000
CY2023Q3 roiv Stock Issued During Period Value Common Share Related To Settlement Of Warrants Value
StockIssuedDuringPeriodValueCommonShareRelatedToSettlementOfWarrantsValue
83264000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
587000
CY2023Q3 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
-20873000
CY2023Q3 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
35050000
CY2023Q3 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
196000
CY2023Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2023Q3 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
49318000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3602000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1325633000
us-gaap Profit Loss
ProfitLoss
-222434000
us-gaap Profit Loss
ProfitLoss
-658963000
us-gaap Share Based Compensation
ShareBasedCompensation
121860000
us-gaap Share Based Compensation
ShareBasedCompensation
98578000
us-gaap Gain Loss On Investments
GainLossOnInvestments
63601000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-53413000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
102137000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-76045000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
110387000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
25036000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9725000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11426000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3160000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3316000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
12360000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5295000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
12206000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
26279000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-18057000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
10142000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-16474000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12390000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3444000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4154000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8244000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-14566000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-459635000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-446359000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3402985000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1961000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
678000
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
110387000
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
47500000
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
83679000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-511000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3294559000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36346000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
199822000
roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
0
roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
6000000
roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
3000000
roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
14471000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
662000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
907000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8891000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42142000
roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
21128000
roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
5788000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
754439000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
648000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
587000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000
roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
0
roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
41000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-769690000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
215349000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2303000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1571000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4521581000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-268927000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6550450000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1692115000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2028869000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1423188000
roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
0
roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
-83258000
roiv Issuance Of Subsidiary Shares In Connection With Debt Renegotiation
IssuanceOfSubsidiarySharesInConnectionWithDebtRenegotiation
11647000
roiv Issuance Of Subsidiary Shares In Connection With Debt Renegotiation
IssuanceOfSubsidiarySharesInConnectionWithDebtRenegotiation
0
roiv Noncash Other
NoncashOther
1869000
roiv Noncash Other
NoncashOther
33000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5400000000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
395600000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-268400000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-489900000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">(C) Concentrations</div> <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Financial instruments that potentially subject the Company to concentration of credit risk include cash, cash equivalents, and marketable securities. The Company maintains cash deposits, cash equivalents, and marketable securities in highly-rated, federally-insured financial institutions in excess of federally insured limits. The Company has established guidelines relative to diversification and maturities to maintain safety and liquidity. The Company has not experienced any credit losses related to these financial instruments and does not believe that it is exposed to any significant credit risk related to these instruments.</div>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1958633000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6494953000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
3112000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3067000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
8169000
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
8169000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1969914000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6506189000
CY2024Q3 us-gaap Cash
Cash
123483000
CY2024Q1 us-gaap Cash
Cash
182665000
CY2024Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1475462000
CY2024Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
6312288000
CY2024Q3 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
359688000
CY2024Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
0
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1958633000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6494953000
CY2024Q3 roiv Marketable Securities Us Government Treasury Securities Current
MarketableSecuritiesUSGovernmentTreasurySecuritiesCurrent
3428021000
CY2024Q1 roiv Marketable Securities Us Government Treasury Securities Current
MarketableSecuritiesUSGovernmentTreasurySecuritiesCurrent
0
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3428021000
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5386654000
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
6494953000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
54843000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
33779000
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1916000
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
3990000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
3112000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3067000
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6889000
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1316000
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
13879000
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
27441000
CY2024Q3 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
13587000
CY2024Q1 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
11012000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
94226000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
80605000
CY2024Q3 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
56299000
CY2024Q1 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
37712000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38849000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49890000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16321000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31815000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
111469000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119417000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3411000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4168000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
5413000
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
9773000
CY2024Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
97000
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
0
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8921000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13941000
roiv Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
3
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2024Q3 roiv Period Of Trailing Trading Days Weighted Average Trading Price Used To Calculate Performance Condition Of Ps Us
PeriodOfTrailingTradingDaysWeightedAverageTradingPriceUsedToCalculatePerformanceConditionOfPSUs
P30D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.558
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.056
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.10
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.013
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
ef20034554_10q_htm.xml Edgar Link completed
0001140361-24-046019-index-headers.html Edgar Link pending
0001140361-24-046019-index.html Edgar Link pending
0001140361-24-046019.txt Edgar Link pending
0001140361-24-046019-xbrl.zip Edgar Link pending
ef20034554_10q.htm Edgar Link pending
ef20034554_ex10-45.htm Edgar Link pending
ef20034554_ex10-46.htm Edgar Link pending
ef20034554_ex31-1.htm Edgar Link pending
ef20034554_ex31-2.htm Edgar Link pending
ef20034554_ex32-1.htm Edgar Link pending
ef20034554_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roiv-20240930.xsd Edgar Link pending
Show.js Edgar Link pending
roiv-20240930_def.xml Edgar Link unprocessable
roiv-20240930_lab.xml Edgar Link unprocessable
roiv-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
roiv-20240930_cal.xml Edgar Link unprocessable